BioSpecifics Technologies Corp.
BSTC
BSTC was delisted on the 1st of December, 2020.
1 hedge funds and large institutions have $204K invested in BioSpecifics Technologies Corp. in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 112 closing their positions.
99% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 112
99% less funds holding
Funds holding: 113 → 1 (-112)
100% less capital invested
Capital invested by funds: $254M → $204K (-$254M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS AM
Chicago,
Illinois
|
+$184K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$29.9M |
| 2 |
BlackRock
New York
|
-$23.8M |
| 3 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$19.5M |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$17.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$16.5M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
Citigroup
New York
| – | -$23K | -439 | Closed |
|
102
Osaic Holdings
Scottsdale,
Arizona
| – | -$14K | -253 | Closed |
|
|
AF
103
Allworth Financial
Folsom,
California
| – | -$11K | -200 | Closed |
|
104
Rockefeller Capital Management
New York
| – | -$5K | -105 | Closed |
|
|
S
105
SignatureFD
Atlanta,
Georgia
| – | -$4K | -70 | Closed |
|
|
PA
106
Parallel Advisors
San Francisco,
California
| – | -$3K | -62 | Closed |
|
107
Bank Julius Baer & Co
Zurich,
Switzerland
| – | -$3K | -50 | Closed |
|
108
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$2K | -30 | Closed |
|
109
AssetMark Inc
Concord,
California
| – | -$1K | -25 | Closed |
|
110
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$1K | -16 | Closed |
|
111
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$1K | -10 | Closed |
|
BSTC Hedge Fund Activity: Q4 2020 in Review
1 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q4 2020, worth a combined $204K — down 100% from $254M a quarter earlier.
Sellers outnumbered buyers: 112 funds closed out of BSTC and 1 opened new positions — a net loss of 111 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was UBS AM, opening a new position worth an estimated $184K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $29.9M sold.
- 1 institutional investor held BioSpecifics Technologies Corp. (BSTC) as of Q4 2020, down from 113 in Q3 2020.
- Funds reported $204K of BioSpecifics Technologies Corp. stock for Q4 2020, down 100% quarter-over-quarter.
- 1 fund opened new BioSpecifics Technologies Corp. positions in Q4 2020 and 112 closed out, a net change of -111 holders.
- The largest BioSpecifics Technologies Corp. buyer in Q4 2020 was UBS AM, an estimated $184K added.
- The largest BioSpecifics Technologies Corp. seller in Q4 2020 was Renaissance Technologies, an estimated $29.9M sold.
Based on aggregated 13F filings for Q4 2020.